NCT07656935

Brief Summary

This study aims to evaluate the association between bladder wall thicknes and treatment response in children presenting with enuresis or lower urinary tract dysfunction.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 18, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
Last Updated

June 18, 2026

Status Verified

June 1, 2026

Enrollment Period

1.9 years

First QC Date

June 16, 2026

Last Update Submit

June 16, 2026

Conditions

Keywords

Bladder wall thicknessEnuresisLower urinary tract disorder

Outcome Measures

Primary Outcomes (1)

  • Bladder Wall Thickness Measured by Ultrasonography in Children With Lower Urinary Tract Symptoms and Enuresis

    Bladder wall thickness measured by transabdominal ultrasonography and compared between children with lower urinary tract symptoms and those with enuresis.

    Baseline

Study Arms (2)

Enuresis

Patients with a diagnosis of enuresis who had bladder wall measurements before treatment

Diagnostic Test: Bladder Wall Thickness Measurement by Ultrasonography

Lower urinary tract disorder

Patients with a diagnosis of lower urinary tract disorder who had bladder wall measurements before treatment

Diagnostic Test: Bladder Wall Thickness Measurement by Ultrasonography

Interventions

Transabdominal ultrasonographic measurement of bladder wall thickness was performed in children with enuresis and lower urinary tract symptoms to evaluate its diagnostic value and predictive value for treatment response.

EnuresisLower urinary tract disorder

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the Pediatric Urology Clinic of Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for enuresis or lower urinary tract disorders and underwent evaluation for bladder wall thickness using ultrasonography.

You may qualify if:

  • Diagnosed with lower urinary tract disorder or enuresis
  • Undergoing transabdominal ultrasonographic measurement of bladder wall thickness
  • Patients between 5-17 years old

You may not qualify if:

  • Patients with neurogenic voiding dysfunction
  • Lack of data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sancaktepe Ilhan Varank Training and Research Hospital

Istanbul, Sancaktepe, 34000, Turkey (Türkiye)

Location

Related Publications (2)

  • Cammisa I, Ferrara P. The Predictive Role of Bladder Ultrasound in Children with Nocturnal Enuresis: A Comprehensive Overview. Children (Basel). 2025 Apr 17;12(4):520. doi: 10.3390/children12040520.

    PMID: 40310223BACKGROUND
  • Riahinezhad M, Merikhi A, Gheisari A, Golabbakhsh A, Khounsarian F. Usage of ultrasound indices in nocturnal enuresis treated with desmopressin therapy. Am J Clin Exp Urol. 2023 Jun 15;11(3):220-227. eCollection 2023.

    PMID: 37441438BACKGROUND

MeSH Terms

Conditions

Nocturnal EnuresisEnuresis

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 16, 2026

First Posted

June 18, 2026

Study Start

September 1, 2024

Primary Completion

August 1, 2026

Study Completion

August 1, 2026

Last Updated

June 18, 2026

Record last verified: 2026-06

Locations